FA
MDT icon

Fagan Associates’s Medtronic MDT Stock Holding History

Fagan Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,495
Closed -$1.17M – 103
2016
Q3 		$1.17M Buy
13,495
+1,375
+11% +$120K 0.71% 40
2016
Q2 		$1.05M Buy
+12,120
New +$980K 0.68% 44

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fagan Associates's MDT Position: Q4 2016 in Review

Fagan Associates sold out of Medtronic (MDT) in Q4 2016, closing a stake of 13,495 shares — an estimated $1.17M sold.

Fagan Associates first reported a position in MDT in Q2 2016 and held it in 2 quarters. The position peaked at $1.17M in Q3 2016. 1,268 funds tracked by Wall St. Rank hold MDT as of Q4 2016.

  • Fagan Associates reported no remaining Medtronic position as of Q4 2016 after selling out during the quarter.
  • Fagan Associates sold 13,495 Medtronic shares in Q4 2016, an estimated $1.17M.
  • Fagan Associates first reported a position in Medtronic in Q2 2016 and held it in 2 quarters.
  • Fagan Associates's Medtronic position peaked at $1.17M in Q3 2016.
  • 1,268 funds tracked by Wall St. Rank held Medtronic as of Q4 2016.

Based on Fagan Associates's 13F filing for Q4 2016, filed 2 Feb 2017.